Journals / MN Oftalmoloji / 2011 / Cilt: 18 - Sayı: 3

Outcomes of amniotic membrane transplantation in noninfectious ocular surface diseases

Nonenfeksiyöz oküler yüzey hastalıklarında amniyon membran transplantasyonu sonuçlarımız

Pages
176–181
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Amniotic membrane transplantation can be performed safely for ocular surface reconstruction in patients with noninfectious ocular surface diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate the efficacy of amniotic membrane transplantation in noninfectious ocular surface diseases.
📊
Key Findings & Data:Materials and Metod: Eightysix eyes of the 86 patients who had amniotic membrane transplantation were included in the study.
💡
Conclusion & Impact:Amniotic membrane transplantation can be performed safely for ocular surface reconstruction in patients with noninfectious ocular surface diseases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate the efficacy of amniotic membrane transplantation in noninfectious ocular surface diseases. Materials and Metod: Eightysix eyes of the 86 patients who had amniotic membrane transplantation were included in the study. Results: The mean age of the patients was 50.9±23.7 (6-88) years. There were 48 (55.8%) male and 38 (44.2%) female patients. Amniotic membrane transplantation (AMT) was performed in cases with symblepharon and chemical burn 36, bullous keratopathy 23, conjunctival mass 9, exposure keratopathy 8, corneal ulcer secondary to rheumatoid arthritis 3, band keratopathy (4), vernal conjunctivitis 3. The mean epithelialisation time after AMT was 22.06 ±8.20 days (range 7-42 days) in 80.2% of the cases. Best corrected visual acuity was improved in 44 (51.1%) patients, unchanged in 36 (41.8%) patients and decreased in 8 (6.97%) patients. Conclusion: Ocular surface diseases can cause severe visual loss, cosmetic defects and chronic irritation and may reduce quality of life. Amniotic membrane transplantation can be performed safely for ocular surface reconstruction in patients with noninfectious ocular surface diseases.

Özet

Amaç: Değişik nonenfeksiyöz oküler yüzey hastalıkları nedeni ile amniyon membran trans - plan tasyonu yapılan olgularımızda postoperatif sonuçları değerlendirmek. Gereç ve Yöntem: Ocak 2004-Temmuz 2010 tarihleri arasında kliniğimizde farklı oküler yüzey hastalıkları nedeni ile amniyon membran transplantasyonu (AMT) uygulanan 86 hastanın 86 gözü incelendi. Bulgular: Olguların 48’i (%55,8) erkek, 38’i (%44,2) kadın idi. Ortalama yaş 50,9±23,7 (6-88) yıl idi. Otuz altı olguya kimyasal yanık ve semblefaron, 23 olguya büllöz keratopati, 9 olguya konjunktiva tümörü, 8 olguya ekspojur keratopati, 3 olguya romatoid artrite sekonder korneal ülser, 4 olguya bant keratopati, 3 olguya vernal konjunktivit nedeni ile AMT yapıldı. Olguların %80,2’sinde ortalama 22,06±8,20 günde epitelizasyon sağlandı. Epitelizasyon en kısa 7, en uzun 42 günde gerçekleşti. Görme keskinliği 44 hastada arttı (%51,1), 36 hastada aynı seviyede kaldı (%41,8), 6 hastada ise azaldı (%6,97). Sonuç: Oküler yüzey hastalıkları ciddi görme kayıpları yanında kozmetik kusurlara ve kronik iritasyona da neden olarak kişinin yaşam kalitesini azaltabilir. Bu hastalıkların tedavisinde amniyon membran transplantasyonu güvenle uygulanmaktadır

🔖

Cite This Article

CANSEVEN, S., TÜRKOĞLU, E. B., BURCU, A., ÖRNEK, F. (2011). Outcomes of amniotic membrane transplantation in noninfectious ocular surface diseases. MN Oftalmoloji, Cilt: 18 - Sayı: 3, 176–181. https://ajindex.com/articles/295788

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic Membran Transplantation: A review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol 2007;55:251-60
  2. Azuara-Blanco A. Pillai CT. Dua HS. Amnion membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999; 83:399-402
  3. Kruse FE. Joussen AM. Rohrschneider K. et al. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol 2000;238: 68-75
  4. Shimmura S. Shimazaki J. Ohashi Y. Tsubota K. Antiinflam - matory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001;20:408-13
  5. Dua H. Gomes J. King A. The Amniotic Membrane in Ophthalmology. Survey of Ophthalmol 2004;49:51-77
  6. Meller D, Pires RTF, Tseng SCG. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol 2002;86:463-71
  7. Anderson OF. Ellies P. Pires RTF. Tseng SCG. Amniotic membrane transplantation for partial limbal stern cell deficiency. Br J Ophthalmol 2001; 85:567-75
  8. Pires RTF. Tseng SCG. Prabhasawat P. et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol 1999;117:1291-7
  9. Espana EM. Grueterich M. Sandovel H. et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg 2003;29:279-84
  10. Hanada K. Shimazaki J. Shimmura S. Tsubota K. Multila yered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol 2001;131:324-31
  11. Lee SH. Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997;123:303-12
  12. Chen HJ. Pires RT. Tseng SC. Amniotic membrane transplan - ta tion for severe neurotrophic corneal ulcers. Br J Ophthalmol 2000;84:826-33
  13. Sridhar MS. Sangwan VS. Bansal AK. Rao GN. Amniotic membrane transplantation in the management of shield ulcers of vernal keratoconjunctivitis. Ophthalmology 2001;108: 1218-22
  14. Pelegrin L. Gris O. Adán A. Plazas A. Superficial keratectomy and amniotic membrane patch in the treatment of corneal plaque of vernal keratoconjunctivitis. Eur J Ophthalmol 2008; 18:131-3
  15. Kwon YS. Kim JC. New treatment for band keratopaty: Superficial lamellar keratectomy, EDTA chelation and Amniotic membrane transplantation. J Korean Med Sci 2004; 19:611-5
  16. Anderson OF. Prabhasawat P. Alfonso E.